Ticker LaunchFiled, not priced · AXTN
Akston Biosciences Corp
Akston Biosciences Corp publicly filed a registration statement on Form S-1 on Oct 8, 2025 for a proposed initial public offering on NYSE American under the ticker AXTN, and has not yet priced. Its latest amendment was filed on May 4, 2026. Underwriters named in the filing: ThinkEquity.
Akston Biosciences Corp is a pet biotechnology company developing and commercializing biopharmaceutical products for cats, dogs and other companion animals, targeting the pet health market with veterinary care and pharmaceutical products.
- Status
- Filed, not priced
- Ticker
- AXTN
- Exchange
- NYSE American
- First filed
- Oct 8, 2025
- Latest amendment
- May 4, 2026
- Underwriters
- ThinkEquity
- Sector
- Biotech & pharma
- Country / state
- MA
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Oct 8, 2025
- Latest amendment May 4, 2026
- All filings on EDGAR CIK 1776612
Other companies in the IPO pipeline
- CGL Logistics Holdings LtdOct 23, 2025
- Boundless GroupOct 10, 2025
- Law's Business Group Holding LtdOct 6, 2025
- Cansince Innovations Inc.Sep 29, 2025
- Sharewow LtdSep 29, 2025
- Seahawk Recycling Holdings, Inc.Sep 25, 2025